Clinical research on postoperative efficacy and related factors of early simulation hyperbaric oxygen therapy for severe craniocerebral injury. | Canada Hyperbarics Skip to main content
Clinical Study Pakistan journal of pharmaceutical sciences 2016

Clinical research on postoperative efficacy and related factors of early simulation hyperbaric oxygen therapy for severe craniocerebral injury.

Xu L, Li B, Yang C, Li C, Peng Y — Pakistan journal of pharmaceutical sciences, 2016

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers compared the clinical efficacy of simulation hyperbaric oxygen therapy (HBOT) versus conventional treatment in 108 severe craniocerebral injury patients requiring ventilator support post-operation.

What They Found

The simulation HBOT group showed significantly better GOS scores (p<0.05) compared to the control group. Patients receiving simulation HBOT also experienced significant increases in oxygen saturation (SjvO2, PjO2, PaO2, SaO2) and significant decreases in serum lactic acid and blood glucose (all p<0.05).

What This Means for Canadian Patients

This study suggests that simulation hyperbaric oxygen therapy could be a beneficial adjunctive treatment for Canadian patients with severe craniocerebral injuries post-surgery. It may improve neurological outcomes and physiological markers, potentially leading to better recovery.

Canadian Relevance

There is no direct Canadian connection to this study.

Study Limitations

The study's findings may be limited by its single-center design and specific patient population, potentially affecting generalizability.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Neurological
Source Pubmed
PubMed ID 27005496
Year Published 2016
Journal Pakistan journal of pharmaceutical sciences
MeSH Terms Adult; Age Factors; Aged; Blood Glucose; Brain Injuries; Computer Simulation; Critical Care; Female; Glasgow Outcome Scale; Humans; Hyperbaric Oxygenation; Lactic Acid; Length of Stay; Male; Middle Aged

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.